Overcoming sample-selection challenges in economic comparisons of drug and non-drug therapy: The case of overactive bladder

被引：0
|
作者：
Ollendorf, DA
Jumadilova, Z
Varadharajan, S
Girase, P
机构：
[1] Pharmetr Inc, Watertown, MA USA
[2] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62623-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：254 / 254
页数：1
相关论文
共 4 条
  • [1] Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults
    Alhasso, A. A.
    McKinlay, J.
    Patrick, K.
    Stewart, L.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [2] Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults
    Rai, Bhavan Prasad
    Cody, June D.
    Alhasso, Ammar
    Stewart, Laurence
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (12):
  • [3] A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology
    Rovner, Eric S.
    Carlson, Kevin, V
    Deal, Anna S.
    Nair, Kavita, V
    Oakkar, Eva E.
    Park, Julie
    Gemmen, Eric
    Kristy, Rita M.
    Gooch, Katherine L.
    Schermer, Carol R.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2018, 70 : 83 - 87
  • [4] Development of a Prospective, Non-Interventional, Longitudinal, Multicenter Registry Study of Patients Initiating a New Course of Drug Therapy for Overactive Bladder (OAB)PERSPECTIVE
    Kristy, Rita
    Carlson, Kevin V.
    Deal, Anna S.
    Nair, Kavita V.
    Rovner, Eric S.
    Gemmen, Eric
    Oakkar, Eva E.
    Park, Julie
    Velentgas, Priscilla
    Bradt, Pamela
    Gooch, Katherine
    Schermer, Carol
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 537 - 537
1